A. Heidenreich, P. Bastian, J. Bellmunt, M. Bolla, S. Joniau et al., EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent???Update 2013, European Urology, vol.65, issue.1, pp.124-161, 2014.
DOI : 10.1016/j.eururo.2013.09.046

G. Aus, C. Abbou, M. Bolla, A. Heidenreich, H. Schmid et al., EAU Guidelines on Prostate Cancer, European Urology, vol.48, issue.4, pp.546-51, 2005.
DOI : 10.1016/j.eururo.2005.06.001

A. Heidenreich, P. Bastian, J. Bellmunt, M. Bolla, S. Joniau et al., EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer, European Urology, vol.65, issue.2, pp.467-79, 2014.
DOI : 10.1016/j.eururo.2013.11.002

M. Bjurlin, X. Meng, L. Nobin, J. Wysock, J. Lepor et al., Optimization of Prostate Biopsy, Urologic Clinics of North America, vol.41, issue.2, pp.648-58, 2014.
DOI : 10.1016/j.ucl.2014.01.011

G. Murphy, M. Haider, S. Ghai, and B. Sreeharsha, The Expanding Role of MRI in Prostate Cancer, American Journal of Roentgenology, vol.201, issue.6, 2013.
DOI : 10.2214/AJR.12.10178

J. Park, C. Kim, S. Park, B. Park, H. Lee et al., Prostate Cancer: Role of Pretreatment Multiparametric 3-T MRI in Predicting Biochemical Recurrence After Radical Prostatectomy, American Journal of Roentgenology, vol.202, issue.5, pp.459-65, 2014.
DOI : 10.2214/AJR.13.11381

A. Hövels, R. Heesakkers, E. Adang, G. Jager, S. Strum et al., The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis, Clinical Radiology, vol.63, issue.4, pp.387-95, 2008.
DOI : 10.1016/j.crad.2007.05.022

C. Bastide, P. Beuzeboc, L. Cormier, G. Fromont, C. Hennequin et al., Recommandations en onco-urologie 2013 du CCAFU: cancer de la prostate, Prog Urol, vol.2313, pp.67-101, 2013.

C. Rousseau, T. Rousseau, L. Campion, J. Lacoste, G. Aillet et al., Laparoscopic Sentinel Lymph Node Versus Hyperextensive Pelvic Dissection for Staging Clinically Localized Prostate Carcinoma: A Prospective Study of 200 Patients, Journal of Nuclear Medicine, vol.55, issue.5, pp.753-761, 2014.
DOI : 10.2967/jnumed.113.129023

URL : http://jnm.snmjournals.org/content/55/5/753.full.pdf

H. Jadvar, Prostate Cancer: PET with 18F-FDG, 18F- or 11C-Acetate, and 18F- or 11C-Choline, Journal of Nuclear Medicine, vol.52, issue.1, pp.81-90, 2011.
DOI : 10.2967/jnumed.110.077941

URL : http://jnm.snmjournals.org/content/52/1/81.full.pdf

T. Degrado, S. Baldwin, S. Wang, M. Orr, R. Liao et al., Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers, J Nucl Med, vol.42, pp.1805-1819, 2001.

L. Evangelista, F. Zattoni, A. Guttilla, G. Saladini, F. Zattoni et al., Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer, Clinical Nuclear Medicine, vol.38, issue.5, pp.305-319, 2013.
DOI : 10.1097/RLU.0b013e3182867f3c

M. Beheshti, L. Imamovic, G. Broinger, R. Vali, P. Waldenberger et al., F Choline PET/CT in the Preoperative Staging of Prostate Cancer in Patients with Intermediate or High Risk of Extracapsular Disease: A Prospective Study of 130 Patients, Radiology, vol.254, issue.3, pp.925-958, 2010.
DOI : 10.1148/radiol.09090413

B. Krause, M. Souvatzoglou, and U. Treiber, Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates, Urologic Oncology: Seminars and Original Investigations, vol.31, issue.4, pp.427-462, 2013.
DOI : 10.1016/j.urolonc.2010.08.008

M. Picchio, A. Briganti, S. Fanti, A. Heidenreich, B. Krause et al., The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer, European Urology, vol.59, issue.1, pp.51-60, 2011.
DOI : 10.1016/j.eururo.2010.09.004

S. Kwee, H. Wei, I. Sesterhenn, D. Yun, and M. Coel, Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET, J Nucl Med, vol.47, pp.262-271, 2006.

U. Nestle, S. Kremp, A. Schaefer-schuler, C. Sebastian-welsch, D. Hellwig et al., Comparison of different methods for delineation of 18F-FDG PETpositive tissue for target volume definition in radiotherapy of patients with nonsmall cell lung cancer, J Nucl Med, vol.46, pp.1342-1350, 2005.

F. Gallivanone, C. Canevari, L. Gianolli, C. Salvatore, D. Rosa et al., A partial volume effect correction tailored for 18F-FDG-PET oncological studies, Biomed Res Int, p.780458, 2013.
DOI : 10.1155/2013/780458

URL : http://doi.org/10.1155/2013/780458

D. Oprea-lager, A. Vincent, R. Van-moorselaar, W. Gerritsen, A. Van-den-eertwegh et al., Dual-Phase PET-CT to Differentiate [18F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer, PLoS ONE, vol.154, issue.2, 2012.
DOI : 10.1371/journal.pone.0048430.t003

URL : https://doi.org/10.1371/journal.pone.0048430

M. Beheshti and W. , PET Imaging of Prostate Cancer Using Radiolabeled Choline, PET Clinics, vol.4, issue.2, pp.173-84, 2009.
DOI : 10.1016/j.cpet.2009.06.003

C. Steiner, H. Vees, H. Zaidi, M. Wissmeyer, O. Berrebi et al., Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence, Nuklearmedizin, vol.48, issue.1, pp.1-9, 2009.
DOI : 10.3413/nukmed-0194

J. Garcia, G. Cuberas, E. Riera, M. Soler, M. Moragas et al., Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence, Nuclear Medicine Communications, vol.36, issue.1, pp.8-15, 2015.
DOI : 10.1097/MNM.0000000000000207

D. Visvikis, M. Hatt, F. Tixier, C. Le-rest, and C. , The age of reason for FDG PET image-derived indices, European Journal of Nuclear Medicine and Molecular Imaging, vol.25, issue.3, pp.1670-1672, 2012.
DOI : 10.1038/nbt1306

URL : https://hal.archives-ouvertes.fr/inserm-00733622

A. De-langen, A. Vincent, L. Velasquez, H. Van-tinteren, R. Boellaard et al., Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis, Journal of Nuclear Medicine, vol.53, issue.5, pp.701-709, 2012.
DOI : 10.2967/jnumed.111.095299

, Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

©. Copyright, . Mathieu, . Ferrer, . Carlier, . Colombié et al., This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms